|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.00 PLN | +0.68% |
|
-1.00% | -12.63% |
| 05-27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 05-15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 198.2 | +67.68% | 1 | ||||
| 56.55 | -2.52% | 11 | ||||||
| 22.29 | +1.53% | 7 | ||||||
| 8.8 | +70.21% | 10 | ||||||
| - | - | 48.3 | +28.83% | 1 | ||||
| 35.4 | -6.3% | 5 | ||||||
| 5.9 | -16.9% | 5 | ||||||
| - | 44,500 | +65.43% | 2 | |||||
| 8.333 | +67% | 3 | ||||||
| Average | 4,987.08 | +30.55% | 5 | ||||||
| Weighted average by Cap. | 2,249.61 | +15.53% | 7 |
- Stock Market
- Stocks
- SCP Stock
- Sector Scope Fluidics S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
